Sage Journals: Discover world-class research

Open access

Case report

First published 2022-6

Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report

Xiangming Cao, Xiongwei Liu, Simin Wang [...]

Journal of International Medical Research

Open access

Case report

First published 2020-09

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Dora Dias-Santagata, Jochen K. Lennerz, Peter M. Sadow [...]

Thyroid®

Open access

Research article

First published 2021

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2024-10

Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population

Zhiting Wang, Qianlan Yao, Longlong Bao [...]

Thyroid®

Retricted access

Research article

First published 2017-06

Identification of Three Novel Fusion Oncogenes,SQSTM1/NTRK3,AFAP1L2/RET,and PPFIBP2/RET,in Thyroid Cancers of Young Patients in Fukushima

Keita Iyama, Michiko Matsuse, Norisato Mitsutake [...]

Thyroid®

Retricted access

Research article

First published 2020-12

RET,NTRK,ALK,BRAF,and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas

Barbora Pekova, Vlasta Sykorova, Sarka Dvorakova [...]

Thyroid®

Retricted access

Review article

First published 2023-3

An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)

Vanessa Quang Nguyen, Marc Geirnaert

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Patient-reported outcomes following selpercatinib treatment in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer and thyroid cancer,and RET -mutant medullary thyroid cancer in the phase II LIBRETTO-321 trial

Shun Lu, Xiangqian Zheng, Yuping Sun [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-06-28

Response to Selpercatinib in an Adolescent with RET Fusion-Positive Papillary Thyroid Carcinoma with Extensive Intracranial and Pulmonary Metastases

Priya Mahajan, Rajkumar Venkatramani

VideoEndocrinology™

Open access

Research article

First published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Search results